Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Who are the leading players in the Evkeeza market? Key players in the Evkeeza market include the notable Regeneron Pharmaceuticals Inc., contributing significantly to the market growth.

Please note that Evkeeza was originally discovered and developed by Regeneron Pharmaceuticals REGN. In 2022, Ultragenyx signed a licensing agreement with Regeneron for Evkeeza to treat HoFH.